Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
EYEPOINT PHARMACEUTICALS, INC. (EYPT) had Earnings per Share (EPS) (Basic) of $-0.85 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.97M |
|
$-59.73M |
|
$0.72M |
|
$0.24M |
|
$62.99M |
|
$-62.02M |
|
$2.29M |
|
$-59.73M |
|
$-59.73M |
|
$-59.73M |
|
$-59.73M |
|
$-59.73M |
|
$-59.73M |
|
$-62.02M |
|
$-62.40M |
|
70.17M |
|
70.17M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.85 |
$-0.85 |
|
| Balance Sheet Financials | |
$216.11M |
|
$8.86M |
|
$35.59M |
|
$251.69M |
|
$30.09M |
|
-- |
|
$21.42M |
|
$51.51M |
|
$200.18M |
|
$200.18M |
|
$200.18M |
|
69.57M |
|
| Cash Flow Statement Financials | |
$-175.06M |
|
$143.25M |
|
$6.69M |
|
$99.85M |
|
$74.73M |
|
$-25.13M |
|
$21.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
25.36% |
|
-6420.81% |
|
-6420.81% |
|
-- |
|
-6183.44% |
|
-6183.44% |
|
$-177.36M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.34 |
|
0.92 |
|
97.36 |
|
-29.84% |
|
-29.84% |
|
-23.73% |
|
-29.84% |
|
$2.88 |
|
$-2.53 |
|
$-2.49 |
|